Events
Trading Direkt Healthcare 2023-05-22 | Redeye-analytikern om Biovicas avtal i USA
Redeye: Biovica comments on the signed provider contract with MediNcrease Health Plans in the US
Q3 Earnings Call FY22/23
Q2 Earnings Call FY22/23
SEB Healthcare Seminar 2022
Stora Aktiedagen Stockholm 28 November 2022
Redeye Life Science Day 2022 – 24 November 2022
Biovica Company Presentation - 23 November 2022
Redeye Diagnostics Forum – 28 September 2022
CEO Presentation at ABGSC Investor Day – 13 September 2022
Redeye Late Stage Life Science companies – CEO presentation and interview 2 September 2022
CEO interview by Redeye 1 September 2022
CEO presentation AGM 31 August 2022
Market update, 18 August 2022
ABGSC Life Science Summit, 19 May 2022
Capital Markets Day, 17 May 2022
ABGSC Investor Day, 8 December 2021
CEO’s presentation Annual General Meeting 2021
Redeye Diagnostics
Company presentation August 2020
Interview with CEO Anders Rylander
Interview with CEO Anders Rylander
Company presentation May 2020
Capital Market Day 11th of May 2020
Nordnet Nordic Invest, Capital Markets Seminar, 6 mars 2020
Aktiedagen Lund 28 januari
Panelsamtal: Framtidens behandling av cancer på Aktiedagen 28 januari i Lund
Pareto Securities life science analytiker går igenom Biovica
Audiocast, December 6, 2019. Q2 Interim Report
Audiocast, September 19, 2019. Update on clinical development progress
Pareto Securities’ 10th Annual Health Care Conference in Stockholm 5th September 2019
Management presentation directed issue April 2019
Web-cast telephone conference, at 09:00 am CET, March 21
Börsveckans Småbolagsdag 19 februari 2019 – intervju
Börsveckans Småbolagsdag 19 februari 2019 – presentation
Biovica Stora Aktiedagen i Lund 2019-01-29
RedEye LifeScience Dag den 21 november 2018
Bolagspresentationer
>4,500
Numbers of patients in studies
25+
Publications
10
Pharma Contracts